Institutional & Family Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$143K Buy
2,084
+667
+47% +$44.5K 0.02% 163
2024
Q1
$104K Sell
1,417
-84
-6% -$6.46K 0.02% 181
2023
Q4
$122K Hold
1,501
0.02% 171
2023
Q3
$112K Buy
1,501
+140
+10% +$10.8K 0.02% 167
2023
Q2
$105K Buy
1,361
+27
+2% +$2.15K 0.02% 178
2023
Q1
$111K Buy
1,334
+297
+29% +$24.6K 0.02% 169
2022
Q4
$89K Sell
1,037
-136
-12% -$10.8K 0.01% 177
2022
Q3
$72K Sell
1,173
-376
-24% -$23.7K 0.01% 195
2022
Q2
$96K Buy
1,549
+10
+0.6% +$619 0.02% 176
2022
Q1
$91K Hold
1,539
0.01% 204
2021
Q4
$112K Sell
1,539
-4
-0.3% -$276 0.02% 197
2021
Q3
$108K Buy
1,543
+554
+56% +$38.9K 0.02% 230
2021
Q2
$68K Hold
989
0.01% 296
2021
Q1
$64K Buy
989
+169
+21% +$10.9K 0.01% 323
2020
Q4
$48K Sell
820
-38
-4% -$2.29K 0.01% 332
2020
Q3
$54K Sell
858
-87
-9% -$6.03K 0.01% 283
2020
Q2
$73K Sell
945
-405
-30% -$31K 0.02% 268
2020
Q1
$101K Sell
1,350
-45
-3% -$3.11K 0.02% 204
2019
Q4
$91K Sell
1,395
-67
-5% -$4.36K 0.02% 251
2019
Q3
$93K Sell
1,462
-244
-14% -$15.9K 0.02% 226
2019
Q2
$115K Buy
1,706
+1,702
+42,550% +$112K 0.02% 210
2019
Q1
$0 Hold
4
﹤0.01% 854
2018
Q4
$0 Hold
4
﹤0.01% 844
2018
Q3
$0 Hold
4
﹤0.01% 854
2018
Q2
$0 Sell
4
-66
-94% -$4.66K ﹤0.01% 856
2018
Q1
$5K Buy
+70
New +$5.57K ﹤0.01% 591

Other funds holding GILD

Institutional & Family Asset Management's GILD Position: Q2 2024 in Review

Institutional & Family Asset Management increased its Gilead Sciences (GILD) stake by 47% in Q2 2024, buying an estimated $44.5K and bringing the position to 2,084 shares worth $143K. The position accounts for 0.02% of the portfolio, ranked #163.

Institutional & Family Asset Management first reported a position in GILD in Q1 2018 and has held it in 26 quarters since. 1,679 funds tracked by Wall St. Rank hold GILD as of Q2 2024.

  • Institutional & Family Asset Management held 2,084 shares of Gilead Sciences worth $143K as of Q2 2024.
  • Institutional & Family Asset Management bought 667 Gilead Sciences shares in Q2 2024, an estimated $44.5K.
  • Gilead Sciences made up 0.02% of Institutional & Family Asset Management's portfolio in Q2 2024, its #163 holding.
  • Institutional & Family Asset Management first reported a position in Gilead Sciences in Q1 2018 and has held it in 26 quarters since.
  • 1,679 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.

Based on Institutional & Family Asset Management's 13F filing for Q2 2024, filed 5 Jul 2024.